Pliant Therapeutics (PLRX) Prepaid Assets (2019 - 2026)
Pliant Therapeutics (PLRX) posted quarterly Prepaid Assets of $3.1 million for Q1 2026, down 43.53% year-over-year from $5.5 million in Q1 2025, and down 29.84% quarter-over-quarter from $4.5 million in Q4 2025.
Pliant Therapeutics (PLRX) Prepaid Assets (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Prepaid Assets for 8 consecutive years, with $3.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 43.53% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (down 43.53% YoY), while the FY2025 annual figure was $4.5 million, down 31.74% from the prior year.
- Prepaid Assets declined to $3.1 million in Q1 2026 per PLRX's latest filing, from $4.5 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $11.3 million in Q4 2023 and bottomed at $3.1 million in Q1 2026.
- Historically, Prepaid Assets has averaged $6.6 million across 5 years, with a median of $5.8 million in 2022.
- Annual changes were most pronounced in 2023 — Prepaid Assets jumped 155.83% — and 2025, when it plunged 58.24%.
- Pliant Therapeutics' Prepaid Assets stood at $7.1 million in 2022, then surged by 59.49% to $11.3 million in 2023, then slumped by 41.9% to $6.5 million in 2024, then plunged by 31.74% to $4.5 million in 2025, then fell by 29.84% to $3.1 million in 2026.
- Business Quant data shows PLRX's Prepaid Assets at $3.1 million in Q1 2026, $4.5 million in Q4 2025, and $3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pliant Therapeutics | 71.52 Mn | 71.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.14 Mn |
| Mar 31, 2026 | 3.13 Mn |
| Dec 31, 2025 | 4.46 Mn |
| Sep 30, 2025 | 3.79 Mn |
| Jun 30, 2025 | 4.57 Mn |
| Mar 31, 2025 | 5.55 Mn |
| Dec 31, 2024 | 6.54 Mn |
| Sep 30, 2024 | 5.52 Mn |
| Jun 30, 2024 | 10.95 Mn |
| Mar 31, 2024 | 7.51 Mn |
| Dec 31, 2023 | 11.26 Mn |
| Sep 30, 2023 | 10.64 Mn |
| Jun 30, 2023 | 8.89 Mn |
| Mar 31, 2023 | 7.53 Mn |
| Dec 31, 2022 | 7.06 Mn |
| Sep 30, 2022 | 4.16 Mn |
| Jun 30, 2022 | 4.86 Mn |
| Mar 31, 2022 | 5.75 Mn |
| Dec 31, 2021 | 6.76 Mn |
| Sep 30, 2021 | 5.85 Mn |